Fideuram Asset Management Ireland dac Purchases New Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Fideuram Asset Management Ireland opened a new position in Intuitive Surgical in the fourth quarter, buying 8,815 shares worth about $5.0 million.
• Intuitive Surgical reported strong quarterly results, posting $2.50 EPS on revenue of $2.77 billion, both above analyst expectations, with revenue up 23% year over year.
• Despite the solid fundamentals, several analysts trimmed price targets on the stock, though the overall consensus remains Moderate Buy with an average target price of $576.71.

Fideuram Asset Management Ireland dac purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 8,815 shares of the medical equipment provider's stock, valued at approximately $5,035,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Intuitive Surgical by 1,043.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider's stock valued at $760,124,000 after purchasing an additional 1,224,734 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in Intuitive Surgical by 106.6% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider's stock worth $868,667,000 after acquiring an additional 791,516 shares during the last quarter. Amundi grew its holdings in Intuitive Surgical by 29.7% during the 3rd quarter. Amundi now owns 3,227,472 shares of the medical equipment provider's stock worth $1,451,362,000 after acquiring an additional 739,444 shares during the last quarter. Sands Capital Management LLC grew its holdings in Intuitive Surgical by 77.0% during the 3rd quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider's stock worth $599,784,000 after acquiring an additional 583,539 shares during the last quarter. Finally, Victory Capital Management Inc. grew its holdings in Intuitive Surgical by 41.3% during the 3rd quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider's stock worth $868,212,000 after acquiring an additional 567,483 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $423.63 on Friday. The firm's fifty day moving average is $454.60 and its 200-day moving average is $507.01. Intuitive Surgical, Inc. has a 52 week low of $414.30 and a 52 week high of $603.88. The firm has a market cap of $150.03 billion, a P/E ratio of 51.35, a P/E/G ratio of 3.34 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts' consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same period in the prior year, the firm posted $1.81 EPS. The company's quarterly revenue was up 23.0% on a year-over-year basis. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Activity

In other news, EVP Myriam Curet sold 105 shares of the company's stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Mark Brosius sold 645 shares of the company's stock in a transaction on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president directly owned 1,613 shares in the company, valued at approximately $782,321.13. This represents a 28.57% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 5,481 shares of company stock valued at $2,673,871. Company insiders own 0.60% of the company's stock.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical announced Taylor Patton will become Chief Commercial and Marketing Officer effective July 1, while current commercial chief Henry Charlton moves to SVP of Global Business Operations. The change appears to be an internal promotion, suggesting leadership continuity rather than disruption. Article Title
• Positive Sentiment: The company has also highlighted major updates to its da Vinci 5 robotic surgical system, with more than 100 improvements set to roll out to U.S. customers starting in June. Investors may view that as a sign of continued innovation and potential to support procedure growth. Article Title
• Positive Sentiment: Recent commentary from market and research outlets has remained favorable, with articles arguing that Intuitive Surgical’s above-average financial growth and optimistic analyst outlook could make the stock attractive to growth investors. Article Title
• Neutral Sentiment: A market note said Intuitive Surgical underperformed competitors on Wednesday, but the item did not point to a company-specific setback or new fundamental issue. Article Title

Analyst Ratings Changes

A number of equities research analysts have weighed in on ISRG shares. Leerink Partners reduced their target price on shares of Intuitive Surgical from $622.00 to $573.00 and set an "outperform" rating on the stock in a report on Wednesday, April 22nd. TD Cowen reduced their target price on shares of Intuitive Surgical from $660.00 to $585.00 and set a "buy" rating on the stock in a report on Wednesday, April 22nd. Raymond James Financial reduced their target price on shares of Intuitive Surgical from $615.00 to $577.00 and set an "outperform" rating on the stock in a report on Wednesday, April 22nd. Barclays set a $651.00 target price on shares of Intuitive Surgical and gave the stock an "overweight" rating in a report on Thursday, April 23rd. Finally, Truist Financial reduced their target price on shares of Intuitive Surgical from $650.00 to $580.00 and set a "buy" rating on the stock in a report on Wednesday, April 15th. Nineteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $576.71.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.